Montelukast, a medication hailed for its efficacy in treating asthma and allergic rhinitis, has become a household name for ...

This year's spike in cases marks a return to pre-pandemic levels of this infection, which is also called pertussis.

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, making it the first drug cleared in the U.S. for the rare neurodegenerative disorder.

Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. heal ...

On September 13, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published Advisory ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

In the past 60 days, estimates for Krystal Biotech’s 2024 EPS have increased from $2.09 to $2.38. The consensus estimate for 2025 earnings has improved from $4.33 to $7.31. Year to date, shares of ...

Consumers should be aware that some chocolate labeled as "dairy-free" actually contains milk, the U.S. Food and Drug ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

The U.S. vaccine policy landscape is broader and changing more rapidly than at any point in its modern history, and those ...

Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 ...